Frankfurt - Delayed Quote EUR

Nichirei Corporation (NI3.F)

21.40 -0.20 (-0.93%)
At close: 8:10 AM GMT+2
Loading Chart for NI3.F
DELL
  • Previous Close 21.60
  • Open 21.40
  • Bid 21.40 x 200000
  • Ask 21.80 x 200000
  • Day's Range 21.40 - 21.40
  • 52 Week Range 19.00 - 25.00
  • Volume 32
  • Avg. Volume 0
  • Market Cap (intraday) 2.769B
  • Beta (5Y Monthly) 0.04
  • PE Ratio (TTM) 21.62
  • EPS (TTM) 0.99
  • Earnings Date Jul 30, 2024 - Aug 5, 2024
  • Forward Dividend & Yield 0.49 (2.26%)
  • Ex-Dividend Date Sep 27, 2024
  • 1y Target Est --

Nichirei Corporation, through its subsidiaries, engages in the processed food, marine products, meat and poultry products, temperature-controlled logistics, real estate, and biosciences businesses in Japan and internationally. It operates through Processed Foods, Marine, Meat and Poultry, Logistics, and Real Estate segments. The Processed Foods segment engages in the production, processing, and sale of frozen cooked food, agricultural processed food, retort-pouch food, and wellness food products, as well as acerola and packed ice. The Marine segment processes and sells marine products, such as clams, capelin, flatfish, salmon, herring, squids, cod, crabs, pollocks, scallops, mackerels, carpet shell, Pacific ocean perch, prawns, shrimps, oysters, and trout. The Meat and Poultry segment is involved in the processing and sale of meat and poultry products, as well as breeding and sale of chicken. The Logistics segment engages in the provision of distribution, transportation, refrigerated warehousing, storage, cross-docking, and delivery services; construction work and planning services; engineering services, including logistics facility planning, design, and maintenance management services; logistics consulting; distribution center functions; and production and sales of ice. The Real Estate segment leases office buildings and parking lots; and provides real estate management services. It also develops and produces bioscience products comprising molecular diagnostics, biomedical materials, and immunochromatographic diagnostic reagents and devices, contributing to peoples' physical and mental health. The company was formerly known as Nippon Reizo Co. Ltd. and changed its name to Nichirei Corporation in February 1985. Nichirei Corporation was incorporated in 1942 and is headquartered in Tokyo, Japan.

www.nichirei.co.jp

--

Full Time Employees

March 31

Fiscal Year Ends

Recent News: NI3.F

Performance Overview: NI3.F

Trailing total returns as of 6/11/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

NI3.F
302.65%
Nikkei 225
16.95%

1-Year Return

NI3.F
214.23%
Nikkei 225
21.29%

3-Year Return

NI3.F
25,983.61%
Nikkei 225
35.19%

5-Year Return

NI3.F
500,720,550.00%
Nikkei 225
84.56%

Compare To: NI3.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NI3.F

Valuation Measures

Annual
As of 6/10/2024
  • Market Cap

    2.80B

  • Enterprise Value

    3.19B

  • Trailing P/E

    21.85

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.79

  • Price/Book (mrq)

    1.84

  • Enterprise Value/Revenue

    0.79

  • Enterprise Value/EBITDA

    8.66

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    3.60%

  • Return on Assets (ttm)

    4.90%

  • Return on Equity (ttm)

    10.37%

  • Revenue (ttm)

    680.09B

  • Net Income Avi to Common (ttm)

    24.49B

  • Diluted EPS (ttm)

    0.99

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    31.28B

  • Total Debt/Equity (mrq)

    36.83%

  • Levered Free Cash Flow (ttm)

    25.67B

Research Analysis: NI3.F

Company Insights: NI3.F

Research Reports: NI3.F

People Also Watch